SRF

DataTracks Introduces Smart Roll Forward for ESEF Reporting Solution

Retrieved on: 
Thursday, April 13, 2023
Product design, EU, Page footer, Bank statement, Hans Hassle, Annual, SRF, Annual report, European, Header, Online shopping, ESEF, ESMA, XBRL

AMSTERDAM and LONDON, April 13, 2023 /PRNewswire/ -- DataTracks, a global compliance leader in financial reporting, has launched an updated ESEF solution with the groundbreaking 'Smart Roll Forward' functionality.

Key Points: 
  • AMSTERDAM and LONDON, April 13, 2023 /PRNewswire/ -- DataTracks, a global compliance leader in financial reporting, has launched an updated ESEF solution with the groundbreaking 'Smart Roll Forward' functionality.
  • With the latest Smart Roll Forward (SRF) update, DataTracks offers a solution that covers last-minute changes without any hassles.
  • Smart Roll Forward is the latest feature added to DataTracks' ESEF Reporting solution and complements Rainbow software.
  • Pramodh Vittal, Vice President for Product Design, DataTracks, said, "We are excited to announce the launch of our updated ESEF solution, complete with the game-changing Smart Roll Forward functionality.

Genentech Data Highlights Strength of Ophthalmology Portfolio and Commitment to Advancing Eye Care at ARVO 2023

Retrieved on: 
Thursday, April 13, 2023
Technology, Research, Clinical Trials, Biotechnology, Health, Pharmaceutical, Optical, Science, Artificial Intelligence, Retina, ARVO, Abstract, DME, AMD, IL-6, Neovascularization, Diabetic retinopathy, ROG, Blood, RO, UME, SRF, Patient, CST, Annual general meeting, Reading, Artificial intelligence, IRF, Phase, Visual acuity, Roche, Pharmaceutical industry, Faricimab, Genentech, Ophthalmology

“We are particularly encouraged by data indicating that Vabysmo may stabilize blood vessels and reduce fluid in the retina.

Key Points: 
  • “We are particularly encouraged by data indicating that Vabysmo may stabilize blood vessels and reduce fluid in the retina.
  • Genentech recently launched two Phase III trials in UME based on encouraging Phase I safety and efficacy data.
  • Further information on select Genentech abstracts that will be presented at ARVO 2023 can be found in the table below.
  • Follow Genentech on Twitter @Genentech and @GenentechEye and via LinkedIn , and keep up to date with ARVO Annual Meeting news and updates by using the hashtag #ARVO23.

KBRA Analytics Releases The Bank Treasury Newsletter, the Bank Treasury Chart Deck, and Bank Talk

Retrieved on: 
Monday, March 27, 2023
Banking, Data Analytics, Professional Services, Finance, Fed, MBS, FHLB, Federal, RRP, AOCI, SOFR, FDIC, Public policy, Federal Home Loan Banks, Treasury, Term Asset-Backed Securities Loan Facility, Federal Reserve, SRF, United States Department of the Treasury, Bank

KBRA Analytics releases this month’s edition of The Bank Treasury Newsletter, the Bank Treasury Chart Deck, and Bank Talk.

Key Points: 
  • KBRA Analytics releases this month’s edition of The Bank Treasury Newsletter, the Bank Treasury Chart Deck, and Bank Talk.
  • This month’s newsletter, Bank Treasurers Reconsider Asteroid Insurance, reviews the critical steps the Federal Reserve, FDIC, and U.S. Treasury have taken to stabilize financial markets and reassure depositors in the wake of the bank failures this month.
  • Delving into the new Bank Term Funding Program (BTFP), the newsletter compares it to other Fed liquidity programs, including the discount window and the standing repo facility (SRF).
  • In Bank Talk, Ethan and Van discuss the plumbing behind SOFR and how it connects to the rate the Fed pays on its reverse repo (RRP) facility.

AWWA fly-in delegates take water matters to U.S. Congress

Retrieved on: 
Wednesday, March 22, 2023
CERCLA, Legislation, Innovation Act, United States farm bill, PFAS, Superfund, Public, Policy, Quality of life, Development aid, Human, Attention, Rural area, American Water Works Association, Natural Resources Conservation Service, Congress, EPA, Inflation, SRF, Safe Drinking Water Act, Water, AWWA, United States Department of Agriculture, Inflation Reduction Act of 2022, Environment, Whaling, Bank, Medical device, Renewable energy

WASHINGTON, March 22, 2023 /PRNewswire-PRWeb/ -- More than 140 water leaders from throughout the United States gathered in Washington, D.C. today to advocate for smart water policy to members of Congress at the 21st American Water Works Association (AWWA) Water Matters! Fly-In.

Key Points: 
  • AWWA Water Utility Council Chair Ken Lykens noted the fly-in is an annual opportunity "to become the voice for water issues on Capitol Hill."
  • WASHINGTON, March 22, 2023 /PRNewswire-PRWeb/ -- More than 140 water leaders from throughout the United States gathered in Washington, D.C. today to advocate for smart water policy to members of Congress at the 21st American Water Works Association (AWWA) Water Matters!
  • AWWA delegates are meeting with their respective representatives, senators and congressional staffs in more than 300 meetings over the next two days.
  • AWWA Water Utility Council Chair Ken Lykens noted the fly-in is an annual opportunity "to become the voice for water issues on Capitol Hill."

The Scleroderma Research Foundation Will Be Featured on "Behind The Mystery" Presented by The Balancing Act® Airing on Lifetime®

Retrieved on: 
Thursday, February 16, 2023
Human, Stanford University School of Medicine, Rheumatology, Rare Disease Day, Scleroderma Research Foundation, Scleroderma, Division, Melissa, Patient, SRF, Fibrosis, Skin, Research, Rare disease, Family, Mystery, Immunology, Balancing, Heart, Disease, SAN, Medical device, Pharmaceutical industry, Dermatology, Medicine

SAN FRANCISCO, Feb. 16, 2023 /PRNewswire/ -- The Scleroderma Research Foundation (SRF) will shine a light on scleroderma—a rare, often misdiagnosed disease—on "Behind The Mystery," a specialized series presented by The Balancing Act® and airing on Lifetime® on February 20 and on Rare Disease Day, February 28. Scleroderma Research Foundation Founding Board Member Susan Feniger, Dr. Lorinda Chung, Professor of Medicine and Dermatology, Division of Immunology and Rheumatology at Stanford University School of Medicine, and scleroderma patient Melissa will share insights about the disease and research developments supported by the Scleroderma Research Foundation—the country's first and leading nonprofit investor in medical research into scleroderma.

Key Points: 
  • Scleroderma Research Foundation Founding Board Member Susan Feniger, Dr. Lorinda Chung, Professor of Medicine and Dermatology, Division of Immunology and Rheumatology at Stanford University School of Medicine, and scleroderma patient Melissa will share insights about the disease and research developments supported by the Scleroderma Research Foundation—the country's first and leading nonprofit investor in medical research into scleroderma.
  • "The Scleroderma Research Foundation is laser-focused on funding and facilitating research in order to advance treatments and find a cure for scleroderma so that people don't need to suffer," says Joanne Gold, Executive Director of the Scleroderma Research Foundation.
  • "The Scleroderma Research Foundation works with top leaders across a variety of fields in order to expand our knowledge of the causes of scleroderma and improve treatments for patients.
  • The Scleroderma Research Foundation funds and facilitates the most promising, highest quality research aimed at improved therapies and, ultimately, a cure for scleroderma.

RetinAI launches Discovery CORE: an AI-powered, collaborative platform to accelerate Clinical and Academic Research, and RWE analysis in ophthalmology

Retrieved on: 
Thursday, December 1, 2022
Fortis Healthcare, CORE, AI, University, OCT, SRF, Artificial intelligence, Physician, Elevate, Retina, Discovery, Disease, DICOM, CET, IRF, Research, PED, Data analysis, Registry, Eye, Medical device, Ophthalmology

Discovery CORE and its AI models have been designed to accelerate data analysis and help clinical and academic researchers collaborate more efficiently in real time with their peers on medical and imaging datasets.

Key Points: 
  • Discovery CORE and its AI models have been designed to accelerate data analysis and help clinical and academic researchers collaborate more efficiently in real time with their peers on medical and imaging datasets.
  • The software measures retinal fluid volumes and layer thickness across OCT datasets automatically in real time.
  • Caption: A look at the Discovery CORE platform and its AI.
  • RetinAI is excited to offer Discovery CORE and its AI as a free trial for the first 2 months for users signing up on the platform.

HISTORIC FUNDRAISING - NFT DIGITAL BIO-ART CAMPAIGN

Retrieved on: 
Friday, November 18, 2022
SRF, Research, Degenerative disease, NFT, Electrode, SENS, Digital, Senescence, Request, Strategies for engineered negligible senescence, Ageing, Pharmaceutical industry

SRF is a California 501(c)(3) non-profit working on addressing aging medically through its SENS damage-repair approach (Strategies for Engineered Negligible Senescence).

Key Points: 
  • SRF is a California 501(c)(3) non-profit working on addressing aging medically through its SENS damage-repair approach (Strategies for Engineered Negligible Senescence).
  • Their campaign will highlight each of their 7-Strand research programs to challenge the 7 types of damage that cause aging.
  • In collaboration with digital artist Soliman Lopez, SRF presents VI7A a historic NFT, digital bio-art collection.
  • Each unique NFT artwork will be generated from live data streams from cell cultures by means of electrodes and an oscilloscope.

COP 27 Egypt: PLN shares its biomass co-firing implementation in coal power plants

Retrieved on: 
Tuesday, November 8, 2022
Biomass, PT Perkebunan Nusantara IX, Carbon, Coal-fired power station, COP, PT, Coordinating Ministry for Maritime and Investments Affairs (Indonesia), CO2, Technology, PLN, CFPP, Evy, Transmission, Goal, Maritime, Government, Environment, Perusahaan Listrik Negara, SRF, Renewable energy, Sharm El Sheikh

In the power sector, PT PLN (Persero) will begin to gradually early retire Coal Fired Power Plant (CFPP).

Key Points: 
  • In the power sector, PT PLN (Persero) will begin to gradually early retire Coal Fired Power Plant (CFPP).
  • Meanwhile, to reduce emissions from existing operational CFPPs, PLN has implemented biomass co-firing technology.
  • PLN Director of Transmission and System Planning, Evy Haryadi, has explained that PLN is implementing co-firing technology at 33 CFPPs.
  • The Government also supports local stakeholders to manage municipal waste to be converted to biomass feedstock for PLN co-firing.

Adverum Biotechnologies Reports Third Quarter 2022 Financial Results

Retrieved on: 
Thursday, November 10, 2022
Quality of life, GLOBE, Private Securities Litigation Reform Act, NAMD, Prevalence, Investment, Gene therapy of the human retina, Annual general meeting, Food, Nasdaq, Research, Society, Incidence, Injection, Technology, IRF, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Neovascularization, Severe cognitive impairment, SEC, NASDAQ, American Academy, Patient, AMD, Macular degeneration, Safety, Compliance, U.S. Securities and Exchange Commission, Caregiver, OPTIC, VEGF, Home After Three Months Away, Retina, Standard of care, European Medicines Agency, Drug discovery, SRF, IVT, Pharmaceutical industry, Birth control, Vaccine, Adverum Biotechnologies

REDWOOD CITY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced financial results for the third quarter ended September 30, 2022.

Key Points: 
  • In July 2022, Adverum completed an Investigational New Drug amendment with the U.S. Food and Drug Administration to advance a Phase 2 trial of Ixo-vec in wet AMD.
  • Stock-based compensation expense included in research and development expenses was $1.4 million for the third quarter of 2022.
  • Stock-based compensation expense included in general and administrative expenses was $3.1 million for the third quarter of 2022.
  • Additional risks and uncertainties facing Adverum are set forth under the caption Risk Factors and elsewhere in Adverums Securities and Exchange Commission (SEC) filings and reports, including Adverums Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 filed with the SEC on August 11, 2022.

Boston University Re-Launches Sexual Health Vending Machines

Retrieved on: 
Thursday, November 10, 2022
Leadership, Birth, Partnership, Member of Congress, Education, FC Volna Pinsk, BU, Boston University, Entrepreneurship, Student, Patient, Health minister, STI, Health, SRF, Supreme Court of the United States, Congress, Birth control

BOSTON, Nov. 10, 2022 /PRNewswire/ -- The Boston University (BU) student group 'Students for Reproductive Freedom' (SRF) re-launched its sexual health vending machines at the George Sherman Student Union on the BU campus recently. Over 150 students attended the launch, which was kicked-off by Massachusetts Congresswoman Ayanna Pressley, along with SRF President Dillon Tedesco.

Key Points: 
  • BOSTON, Nov. 10, 2022 /PRNewswire/ --The Boston University (BU) student group 'Students for Reproductive Freedom' (SRF) re-launched its sexual health vending machines at the George Sherman Student Union on the BU campus recently.
  • BU Re-Launches Sexual Health Vending Machines: Students For Reproductive Freedom and TBD Health Partner on Launch
    Through SRF's leadership, the sexual health vending machines launched this spring, and provided critical access to emergency contraption for BU students.
  • TBD Health is a hybrid sexual health company that offers emergency contraception and at-home STI testing backed by access to clinical expertise, on-line learning resources, and a community of peers.
  • TBD Health's self-help services provide safe, secure and private access to care that minimizes the stigma of sexual health while improving the students' education about their own sexual health.